University of Hertfordshire

Standard

New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues. / Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Orsolini, Laura; Guirguis, Amira; Corkery, John Martin; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro.

In: Current Addiction Reports, Vol. 6, No. 2, 23.04.2019, p. 140-152.

Research output: Contribution to journalArticle

Harvard

Schifano, F, Napoletano, F, Chiappini, S, Orsolini, L, Guirguis, A, Corkery, JM, Bonaccorso, S, Ricciardi, A, Scherbaum, N & vento, A 2019, 'New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues', Current Addiction Reports, vol. 6, no. 2, pp. 140-152. https://doi.org/10.1007/s40429-019-00249-z

APA

Schifano, F., Napoletano, F., Chiappini, S., Orsolini, L., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & vento, A. (2019). New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues. Current Addiction Reports, 6(2), 140-152. https://doi.org/10.1007/s40429-019-00249-z

Vancouver

Author

Schifano, Fabrizio ; Napoletano, Flavia ; Chiappini, Stephania ; Orsolini, Laura ; Guirguis, Amira ; Corkery, John Martin ; Bonaccorso, Stefania ; Ricciardi, Angelo ; Scherbaum, Norbert ; vento, alessandro. / New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues. In: Current Addiction Reports. 2019 ; Vol. 6, No. 2. pp. 140-152.

Bibtex

@article{1cd30df8fd55404ba4f8aba1d76e8a31,
title = "New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues",
abstract = "Purpose of the review: A significant increase in the number, type, and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic substances have historically been used in order to achieve altered states of consciousness such as dissociative states. We aimed here at describing both the large number of novel ketamine-like dissociatives and tryptamine/lysergamide/phenethylamine psychedelics available, whilst describing the acute/long term clinical scenarios most commonly associated with their intake. Recent findings: An updated overview of the clinical and clinical pharmacological issues related to some of the most popular NPS categories has been provided, describing both psychosis and remaining psychopathological issues related to them. Conclusions: Although the complex link between NPS and psychiatric illnesses is yet to be fully understood, NPS misuse is now a significant clinical issue and an increasing challenge for clinicians working in both mental health and emergency departments.",
keywords = "New psychoactive substances, NPS, dissociation, Psychedelics, drug-induced psychosis, drug misuse",
author = "Fabrizio Schifano and Flavia Napoletano and Stephania Chiappini and Laura Orsolini and Amira Guirguis and Corkery, {John Martin} and Stefania Bonaccorso and Angelo Ricciardi and Norbert Scherbaum and alessandro vento",
note = "submitted 16 01 2019; revised version submitted 08 02 2019; accepted final 03 04 2019",
year = "2019",
month = apr,
day = "23",
doi = "10.1007/s40429-019-00249-z",
language = "English",
volume = "6",
pages = "140--152",
journal = "Current Addiction Reports",
issn = "2196-2952",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues

AU - Schifano, Fabrizio

AU - Napoletano, Flavia

AU - Chiappini, Stephania

AU - Orsolini, Laura

AU - Guirguis, Amira

AU - Corkery, John Martin

AU - Bonaccorso, Stefania

AU - Ricciardi, Angelo

AU - Scherbaum, Norbert

AU - vento, alessandro

N1 - submitted 16 01 2019; revised version submitted 08 02 2019; accepted final 03 04 2019

PY - 2019/4/23

Y1 - 2019/4/23

N2 - Purpose of the review: A significant increase in the number, type, and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic substances have historically been used in order to achieve altered states of consciousness such as dissociative states. We aimed here at describing both the large number of novel ketamine-like dissociatives and tryptamine/lysergamide/phenethylamine psychedelics available, whilst describing the acute/long term clinical scenarios most commonly associated with their intake. Recent findings: An updated overview of the clinical and clinical pharmacological issues related to some of the most popular NPS categories has been provided, describing both psychosis and remaining psychopathological issues related to them. Conclusions: Although the complex link between NPS and psychiatric illnesses is yet to be fully understood, NPS misuse is now a significant clinical issue and an increasing challenge for clinicians working in both mental health and emergency departments.

AB - Purpose of the review: A significant increase in the number, type, and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic substances have historically been used in order to achieve altered states of consciousness such as dissociative states. We aimed here at describing both the large number of novel ketamine-like dissociatives and tryptamine/lysergamide/phenethylamine psychedelics available, whilst describing the acute/long term clinical scenarios most commonly associated with their intake. Recent findings: An updated overview of the clinical and clinical pharmacological issues related to some of the most popular NPS categories has been provided, describing both psychosis and remaining psychopathological issues related to them. Conclusions: Although the complex link between NPS and psychiatric illnesses is yet to be fully understood, NPS misuse is now a significant clinical issue and an increasing challenge for clinicians working in both mental health and emergency departments.

KW - New psychoactive substances

KW - NPS

KW - dissociation

KW - Psychedelics

KW - drug-induced psychosis

KW - drug misuse

U2 - 10.1007/s40429-019-00249-z

DO - 10.1007/s40429-019-00249-z

M3 - Article

VL - 6

SP - 140

EP - 152

JO - Current Addiction Reports

JF - Current Addiction Reports

SN - 2196-2952

IS - 2

ER -